Inclusion Body Myositis Diagnosis Market: By Test Type, By End-User, and Geography

Inclusion Body Myositis Diagnosis Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test Type (Full blood count, Calcium and Phosphate, Creatine Kinase, Erythrocyte Sedimentation Rate, Fasting Glucose, Nerve conduction, Electromyography, Muscle Biopsy, Others), By End-User (Research Center, Hospitals, Clinics, Diagnostic Laboratories, Others), and Region

Inclusion Body Myositis Diagnosis Market size was valued at US$ 4,603.4 million in 2023 and is poised to grow at a 5.5% CAGR from 2024 to 2030. Inclusion Body Myositis (inclusion body myositis) is a rare and serious muscle disease. It causes inflammation and damage to the muscles, which can lead to weakness and difficulty walking, climbing stairs, or using your hands. inclusion body myositis most often affects people aged 50 years or older. They are more common in men than women. The market is driven by factors such as the increasing incidence of Inclusion Body Myositis due to growing awareness about the disease and its symptoms. Moreover, there is a significant amount of growing population of aging individuals, who are more susceptible to inclusion body myositis. Thus, the rising prevalence of autoimmune diseases that predispose individuals to inclusion body myositis development, as well as an increasing number of research studies on inclusion body myositis is likely to result in better diagnosis and treatment options for the disease in the future, driving the growth of the inclusion body myositis diagnosis market. Additionally, the development of biomarker assays and genetic testing holds promise for early detection and personalized treatment approaches. These advancements not only streamline diagnostic processes but also contribute to improved patient outcomes by facilitating early intervention and tailored management strategies. Increasing awareness among healthcare professionals serves as a pivotal driver for the growth of the inclusion body myositis diagnosis Market. As understanding of inclusion body myositis improves within the medical community, healthcare providers are better equipped to recognize the symptoms, differentiate inclusion body myositis from other neuromuscular disorders, and initiate appropriate management strategies.

Moreover, enhanced awareness fosters proactive screening practices, leading to earlier diagnosis and intervention. Continuous medical education programs and collaborative efforts among healthcare organizations play a crucial role in disseminating knowledge about inclusion body myositis, empowering healthcare professionals to deliver optimal care and support to affected individuals. However, the capital-intensive nature of developing treatments and therapies acts as an entry barrier, deterring potential market entrants. Moreover, the landscape of inclusion body myositis diagnosis is rapidly evolving due to the continuous advancements in diagnostic techniques. Innovations such as electromyography (EMG), muscle biopsy, and magnetic resonance imaging (MRI) have revolutionized inclusion body myositis diagnosis, enabling more accurate and timely identification of the disease. The latest trend in the global Inclusion Body Myositis Diagnosis market is a significant shift towards collaborative efforts between academia and industry for drug development. Recognizing the complexity of inclusion body myositis and the challenges associated with developing effective treatments, there has been a notable increase in collaborative research initiatives between academic institutions, research organizations, and pharmaceutical companies.

Inclusion Body Myositis Diagnosis Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.5%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Inclusion Body Myositis Diagnosis Market Dynamics

The rising incidence of the illness, improvements in diagnostic methods, and the creation of cutting-edge treatment approaches targeted at symptom management and disease progression slowing are what are driving the market for inclusion body myositis. Pharmaceutical companies that conduct research and development for treatments that address the underlying processes of disease, such as immune regulation and protein aggregation, are significant players in the Inclusion Body Myositis Diagnosis Market. The development of novel treatments, including gene therapies and biologics, that have the potential to improve outcomes for people with inclusion body myositis is largely dependent on biotechnology companies. Technological developments are significantly enhancing patient management and diagnosis. Advanced MRI and ultrasonography are non-invasive imaging modalities that improve diagnostic precision; digital health tools enable remote monitoring and customized treatment regimens. Furthermore, the analysis of patient data using artificial intelligence is being investigated to forecast the course of disease and enhance treatment approaches.

Inclusion Body Myositis Diagnosis Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 4,603.4 million

Market CAGR

5.5%

By Test Type

  • Full blood count
  • Calcium and Phosphate
  • Creatine Kinase
  • Erythrocyte Sedimentation Rate
  • Fasting Glucose
  • Nerve conduction
  • Electromyography
  • Muscle Biopsy
  • Others

By End User

  • Research Center
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

Inclusion Body Myositis Diagnosis Market was valued at US$ 4,603.4 million in 2023 and is expected to grow at a 5.5% CAGR from 2024 to 2030.

Acceleron Pharma Inc., Abcuro, Gradalis, Inc., KPI Therapeutics Inc., Milo Biotechnology LLC, and Novartis AG are some of the major players operating in the inclusion body myositis diagnosis market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period.

North America accounts for the largest market share and is expected to be the primary market driver in the inclusion body myositis diagnosis market.

High initial investments and costs are expected to limit the growth of the inclusion body myositis diagnosis market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Inclusion Body Myositis Diagnosis Market Introduction 
2.1.Global Inclusion Body Myositis Diagnosis Market  - Taxonomy
2.2.Global Inclusion Body Myositis Diagnosis Market  - Definitions
2.2.1.Test Type
2.2.2.End User
2.2.3.Region
3.Global Inclusion Body Myositis Diagnosis Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Inclusion Body Myositis Diagnosis Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Inclusion Body Myositis Diagnosis Market  By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Full blood count
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Calcium and Phosphate
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Creatine Kinase
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Erythrocyte Sedimentation Rate
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Fasting Glucose
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Nerve conduction
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Electromyography
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Muscle Biopsy
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Others
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
6.Global Inclusion Body Myositis Diagnosis Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Research Center
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Hospitals
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Clinics
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Diagnostic Laboratories
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Inclusion Body Myositis Diagnosis Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Inclusion Body Myositis Diagnosis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Full blood count
8.1.2.Calcium and Phosphate
8.1.3.Creatine Kinase
8.1.4.Erythrocyte Sedimentation Rate
8.1.5.Fasting Glucose
8.1.6.Nerve conduction
8.1.7.Electromyography
8.1.8.Muscle Biopsy
8.1.9.Others
8.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Research Center
8.2.2.Hospitals
8.2.3.Clinics
8.2.4.Diagnostic Laboratories
8.2.5.Others
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Inclusion Body Myositis Diagnosis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Full blood count
9.1.2.Calcium and Phosphate
9.1.3.Creatine Kinase
9.1.4.Erythrocyte Sedimentation Rate
9.1.5.Fasting Glucose
9.1.6.Nerve conduction
9.1.7.Electromyography
9.1.8.Muscle Biopsy
9.1.9.Others
9.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Research Center
9.2.2.Hospitals
9.2.3.Clinics
9.2.4.Diagnostic Laboratories
9.2.5.Others
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Inclusion Body Myositis Diagnosis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Full blood count
10.1.2.Calcium and Phosphate
10.1.3.Creatine Kinase
10.1.4.Erythrocyte Sedimentation Rate
10.1.5.Fasting Glucose
10.1.6.Nerve conduction
10.1.7.Electromyography
10.1.8.Muscle Biopsy
10.1.9.Others
10.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Research Center
10.2.2.Hospitals
10.2.3.Clinics
10.2.4.Diagnostic Laboratories
10.2.5.Others
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Inclusion Body Myositis Diagnosis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Full blood count
11.1.2.Calcium and Phosphate
11.1.3.Creatine Kinase
11.1.4.Erythrocyte Sedimentation Rate
11.1.5.Fasting Glucose
11.1.6.Nerve conduction
11.1.7.Electromyography
11.1.8.Muscle Biopsy
11.1.9.Others
11.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Research Center
11.2.2.Hospitals
11.2.3.Clinics
11.2.4.Diagnostic Laboratories
11.2.5.Others
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Inclusion Body Myositis Diagnosis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Full blood count
12.1.2.Calcium and Phosphate
12.1.3.Creatine Kinase
12.1.4.Erythrocyte Sedimentation Rate
12.1.5.Fasting Glucose
12.1.6.Nerve conduction
12.1.7.Electromyography
12.1.8.Muscle Biopsy
12.1.9.Others
12.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Research Center
12.2.2.Hospitals
12.2.3.Clinics
12.2.4.Diagnostic Laboratories
12.2.5.Others
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Abcam
13.2.2.Thermo Fischer Scientific
13.2.3.Roche
13.2.4.JOYSBIO Biotechnology
13.2.5.Allengers Medical Systems Limited
13.2.6.Nihon Kohden Corporation
13.2.7.Cadwell Industries Inc.
13.2.8.Electrical Geodesics Inc.
13.2.9.Merck
13.2.10.BIONIX
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Abcam
  • Thermo Fischer Scientific
  • Roche
  • JOYSBIO Biotechnology
  • Allengers Medical Systems Limited
  • Nihon Kohden Corporation
  • Cadwell Industries Inc.
  • Electrical Geodesics Inc.
  • Merck
  • BIONIX

Related Industry Reports